EXEL logo

Exelixis (EXEL) EBITDA

annual EBITDA:

$718.75M+$522.15M(+265.59%)
December 1, 2024

Summary

  • As of today (June 2, 2025), EXEL annual EBITDA is $718.75 million, with the most recent change of +$522.15 million (+265.59%) on December 1, 2024.
  • During the last 3 years, EXEL annual EBITDA has risen by +$418.46 million (+139.35%).
  • EXEL annual EBITDA is now at all-time high.

Performance

EXEL EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEXELincome statement metrics

quarterly EBITDA:

$194.20M+$23.10M(+13.50%)
March 1, 2025

Summary

  • As of today (June 2, 2025), EXEL quarterly EBITDA is $194.20 million, with the most recent change of +$23.10 million (+13.50%) on March 1, 2025.
  • Over the past year, EXEL quarterly EBITDA has increased by +$125.53 million (+182.79%).
  • EXEL quarterly EBITDA is now -31.54% below its all-time high of $283.68 million, reached on June 28, 2024.

Performance

EXEL quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEXELincome statement metrics

TTM EBITDA:

$844.28M+$125.53M(+17.46%)
March 1, 2025

Summary

  • As of today (June 2, 2025), EXEL TTM EBITDA is $844.28 million, with the most recent change of +$125.53 million (+17.46%) on March 1, 2025.
  • Over the past year, EXEL TTM EBITDA has increased by +$614.69 million (+267.73%).
  • EXEL TTM EBITDA is now at all-time high.

Performance

EXEL TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEXELincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

EXEL EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+265.6%+182.8%+267.7%
3 y3 years+139.3%+121.4%+116.8%
5 y5 years+90.2%+253.2%+143.8%

EXEL EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+265.6%-31.5%+560.9%at high+1176.2%
5 y5-yearat high+503.0%-31.5%+560.9%at high+1243.6%
alltimeall timeat high+430.1%-31.5%+411.4%at high+457.0%

EXEL EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$194.20M(+13.5%)
$844.28M(+17.5%)
Dec 2024
$718.75M(+265.6%)
$171.10M(-12.4%)
$718.75M(+13.0%)
Sep 2024
-
$195.30M(-31.2%)
$635.96M(+48.1%)
Jun 2024
-
$283.68M(+313.1%)
$429.38M(+87.0%)
Mar 2024
-
$68.67M(-22.2%)
$229.59M(+16.8%)
Dec 2023
$196.60M(-11.6%)
$88.31M(-882.4%)
$196.60M(+197.2%)
Sep 2023
-
-$11.29M(-113.5%)
$66.16M(-60.1%)
Jun 2023
-
$83.89M(+135.1%)
$165.72M(-2.7%)
Mar 2023
-
$35.69M(-184.7%)
$170.31M(-23.4%)
Dec 2022
$222.36M(-26.0%)
-$42.13M(-147.7%)
$222.36M(-42.0%)
Sep 2022
-
$88.28M(-0.2%)
$383.07M(+9.1%)
Jun 2022
-
$88.48M(+0.9%)
$351.21M(-9.8%)
Mar 2022
-
$87.73M(-26.0%)
$389.41M(+29.7%)
Dec 2021
$300.30M(+151.9%)
$118.58M(+110.1%)
$300.30M(+44.1%)
Sep 2021
-
$56.42M(-55.5%)
$208.43M(+86.5%)
Jun 2021
-
$126.68M(-9279.4%)
$111.78M(+77.9%)
Mar 2021
-
-$1.38M(-105.2%)
$62.84M(-47.3%)
Dec 2020
$119.20M(-68.5%)
$26.71M(-166.4%)
$119.20M(-30.7%)
Sep 2020
-
-$40.23M(-151.7%)
$172.07M(-47.9%)
Jun 2020
-
$77.73M(+41.4%)
$329.99M(-4.7%)
Mar 2020
-
$54.98M(-30.9%)
$346.28M(-8.3%)
Dec 2019
$377.82M(-14.9%)
$79.58M(-32.4%)
$377.82M(-7.8%)
Sep 2019
-
$117.70M(+25.2%)
$409.84M(-2.8%)
Jun 2019
-
$94.03M(+8.7%)
$421.76M(+1.8%)
Mar 2019
-
$86.52M(-22.5%)
$414.31M(-6.8%)
Dec 2018
$443.77M(+163.5%)
$111.60M(-13.9%)
$444.46M(+19.4%)
Sep 2018
-
$129.61M(+49.7%)
$372.12M(+13.7%)
Jun 2018
-
$86.58M(-25.8%)
$327.38M(+24.2%)
Mar 2018
-
$116.68M(+197.2%)
$263.59M(+56.5%)
Dec 2017
$168.44M(-565.8%)
$39.26M(-53.7%)
$168.44M(-0.4%)
Sep 2017
-
$84.87M(+272.6%)
$169.04M(+108.6%)
Jun 2017
-
$22.78M(+5.8%)
$81.02M(+137.7%)
Mar 2017
-
$21.54M(-46.0%)
$34.08M(-194.2%)
Dec 2016
-$36.16M(-69.8%)
$39.86M(-1364.5%)
-$36.16M(-66.2%)
Sep 2016
-
-$3.15M(-87.0%)
-$107.01M(-23.0%)
Jun 2016
-
-$24.16M(-50.4%)
-$138.98M(-4.6%)
Mar 2016
-
-$48.70M(+57.2%)
-$145.71M(+22.0%)
Dec 2015
-$119.60M(-45.1%)
-$30.99M(-11.8%)
-$119.47M(-10.9%)
Sep 2015
-
-$35.13M(+13.7%)
-$134.13M(-9.0%)
Jun 2015
-
-$30.89M(+37.5%)
-$147.37M(-16.8%)
Mar 2015
-
-$22.46M(-50.8%)
-$177.21M(-18.4%)
Dec 2014
-$217.73M(+10.9%)
-$45.65M(-5.6%)
-$217.10M(-5.6%)
Sep 2014
-
-$48.36M(-20.4%)
-$229.91M(-2.8%)
Jun 2014
-
-$60.73M(-2.6%)
-$236.49M(+4.7%)
Mar 2014
-
-$62.36M(+6.7%)
-$225.89M(+15.0%)
Dec 2013
-$196.36M(+70.8%)
-$58.46M(+6.4%)
-$196.36M(+10.8%)
Sep 2013
-
-$54.94M(+9.6%)
-$177.27M(+21.4%)
Jun 2013
-
-$50.14M(+52.7%)
-$146.02M(+15.1%)
Mar 2013
-
-$32.83M(-16.6%)
-$126.86M(+10.4%)
Dec 2012
-$114.94M
-$39.36M(+66.1%)
-$114.94M(+418.1%)
Sep 2012
-
-$23.69M(-23.5%)
-$22.18M(-126.2%)
DateAnnualQuarterlyTTM
Jun 2012
-
-$30.98M(+48.2%)
$84.62M(-16.0%)
Mar 2012
-
-$20.90M(-139.2%)
$100.79M(+0.7%)
Dec 2011
$100.07M(-238.0%)
$53.39M(-35.8%)
$100.07M(+185.5%)
Sep 2011
-
$83.11M(-661.2%)
$35.05M(-170.3%)
Jun 2011
-
-$14.81M(-31.5%)
-$49.87M(+2.9%)
Mar 2011
-
-$21.62M(+85.8%)
-$48.47M(-12.1%)
Dec 2010
-$72.52M(-37.3%)
-$11.64M(+545.7%)
-$55.16M(-21.5%)
Sep 2010
-
-$1.80M(-86.6%)
-$70.31M(-14.1%)
Jun 2010
-
-$13.41M(-52.6%)
-$81.85M(-26.2%)
Mar 2010
-
-$28.32M(+5.7%)
-$110.96M(-4.5%)
Dec 2009
-$115.58M(-25.7%)
-$26.78M(+100.7%)
-$116.13M(-6.6%)
Sep 2009
-
-$13.35M(-68.6%)
-$124.31M(-15.3%)
Jun 2009
-
-$42.52M(+27.0%)
-$146.72M(-0.9%)
Mar 2009
-
-$33.49M(-4.2%)
-$148.12M(-6.3%)
Dec 2008
-$155.58M(-14.8%)
-$34.96M(-2.2%)
-$158.09M(-12.6%)
Sep 2008
-
-$35.75M(-18.6%)
-$180.87M(-11.2%)
Jun 2008
-
-$43.92M(+1.1%)
-$203.65M(+4.1%)
Mar 2008
-
-$43.46M(-24.7%)
-$195.58M(+7.1%)
Dec 2007
-$182.65M(+66.3%)
-$57.74M(-1.4%)
-$182.65M(+17.8%)
Sep 2007
-
-$58.54M(+63.3%)
-$155.04M(+25.1%)
Jun 2007
-
-$35.85M(+17.4%)
-$123.96M(+8.8%)
Mar 2007
-
-$30.53M(+1.3%)
-$113.90M(+3.7%)
Dec 2006
-$109.84M(+44.1%)
-$30.13M(+9.7%)
-$109.84M(+4.8%)
Sep 2006
-
-$27.46M(+6.5%)
-$104.82M(+4.1%)
Jun 2006
-
-$25.78M(-2.6%)
-$100.69M(+25.6%)
Mar 2006
-
-$26.47M(+5.4%)
-$80.20M(+5.2%)
Dec 2005
-$76.24M(-14.4%)
-$25.11M(+7.7%)
-$76.24M(+6.2%)
Sep 2005
-
-$23.32M(+340.7%)
-$71.79M(+1.2%)
Jun 2005
-
-$5.29M(-76.5%)
-$70.97M(-19.5%)
Mar 2005
-
-$22.51M(+8.9%)
-$88.14M(-1.0%)
Dec 2004
-$89.06M(+14.8%)
-$20.66M(-8.2%)
-$89.06M(+2.9%)
Sep 2004
-
-$22.50M(+0.2%)
-$86.52M(+2.8%)
Jun 2004
-
-$22.46M(-4.1%)
-$84.19M(+2.9%)
Mar 2004
-
-$23.43M(+29.2%)
-$81.84M(+5.5%)
Dec 2003
-$77.59M(+10.2%)
-$18.13M(-10.1%)
-$77.59M(+5.3%)
Sep 2003
-
-$20.17M(+0.3%)
-$73.67M(+1.2%)
Jun 2003
-
-$20.11M(+4.9%)
-$72.81M(-0.2%)
Mar 2003
-
-$19.18M(+35.0%)
-$72.99M(+5.7%)
Dec 2002
-$70.41M(+31.8%)
-$14.21M(-26.4%)
-$69.06M(-4.3%)
Sep 2002
-
-$19.31M(-4.8%)
-$72.19M(+12.2%)
Jun 2002
-
-$20.29M(+33.0%)
-$64.35M(+14.7%)
Mar 2002
-
-$15.26M(-12.0%)
-$56.09M(+10.9%)
Dec 2001
-$53.43M(+122.6%)
-$17.33M(+51.0%)
-$50.56M(+22.2%)
Sep 2001
-
-$11.48M(-4.6%)
-$41.38M(+14.6%)
Jun 2001
-
-$12.03M(+23.7%)
-$36.12M(+18.4%)
Mar 2001
-
-$9.72M(+19.2%)
-$30.50M(+27.0%)
Dec 2000
-$24.01M(+83.3%)
-$8.16M(+31.4%)
-$24.00M(+51.5%)
Sep 2000
-
-$6.21M(-3.1%)
-$15.85M(+64.4%)
Jun 2000
-
-$6.41M(+98.5%)
-$9.64M(+198.5%)
Mar 2000
-
-$3.23M
-$3.23M
Dec 1999
-$13.10M(-14.4%)
-
-
Dec 1998
-$15.30M
-
-

FAQ

  • What is Exelixis annual EBITDA?
  • What is the all time high annual EBITDA for Exelixis?
  • What is Exelixis annual EBITDA year-on-year change?
  • What is Exelixis quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Exelixis?
  • What is Exelixis quarterly EBITDA year-on-year change?
  • What is Exelixis TTM EBITDA?
  • What is the all time high TTM EBITDA for Exelixis?
  • What is Exelixis TTM EBITDA year-on-year change?

What is Exelixis annual EBITDA?

The current annual EBITDA of EXEL is $718.75M

What is the all time high annual EBITDA for Exelixis?

Exelixis all-time high annual EBITDA is $718.75M

What is Exelixis annual EBITDA year-on-year change?

Over the past year, EXEL annual EBITDA has changed by +$522.15M (+265.59%)

What is Exelixis quarterly EBITDA?

The current quarterly EBITDA of EXEL is $194.20M

What is the all time high quarterly EBITDA for Exelixis?

Exelixis all-time high quarterly EBITDA is $283.68M

What is Exelixis quarterly EBITDA year-on-year change?

Over the past year, EXEL quarterly EBITDA has changed by +$125.53M (+182.79%)

What is Exelixis TTM EBITDA?

The current TTM EBITDA of EXEL is $844.28M

What is the all time high TTM EBITDA for Exelixis?

Exelixis all-time high TTM EBITDA is $844.28M

What is Exelixis TTM EBITDA year-on-year change?

Over the past year, EXEL TTM EBITDA has changed by +$614.69M (+267.73%)
On this page